Philly Leader

Temple Update has conducted an interview with Dr. Anjali Rajadhyaksha, the Director of the Center for Substance Abuse Research at the Lewis Katz School of Medicine, Temple University. Dr. Rajadhyaksha discussed her team's research efforts in exploring the role of endocannabinoids in countering the addictive properties of opioids. The study specifically addresses opioids like morphine and oxycodone, aiming to mitigate their addictive nature while preserving their pain-relieving effects.

Dr. Rajadhyaksha and her team are focused on increasing the levels of endocannabinoids, chemicals that are naturally produced in the body. According to Dr. Rajadhyaksha, this approach may offer a promising solution for reducing the addiction risks associated with opioid medications.

The implications of this research could be significant for managing the opioid crisis, potentially offering a method to sustain the therapeutic benefits of opioids without the burden of addiction.

###